BridgeBio has substantially boosted the development of the new solution for ATTR-CM, employing the compound. Initial trial results suggests significant improvements for individuals diagnosed with this severe condition. https://bridgebio592524.fitnell.com/83263731/company-advances-amyloidosis-management-through-the-therapy